http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-213439-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b262c842f9c7f3c38a61e1f2d892f1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
filingDate 1983-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70f954bbbb121bdd8f5303f1a77bf405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ae0c7f390ae823a97f016b77c3f050
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b818ec799845406c0773e8b45741dff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd6b13e4d7ff02ab99d9e5f6ea0b246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8ad4d8dcaf43176a6a22f9eef253a3d
publicationDate 1984-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-213439-A1
titleOfInvention PROCESS FOR PREPARING PHARMACEUTICALLY UTILIZABLE 10- (3- [4- <2-ETHYLDEKANOATE> -PIPERAZIN-1-YL] -PROPANYL) -2-TRIFLUOR-METHYLPHENOTHIAZIN
abstract The invention relates to a process for the preparation of pharmaceutically utilizable 10- (3- (4- <2-ethyldecanoate> -piperazin-1-yl) -propan-1-yl) -2-trifluoromethylphenothiazine, which is used as an antipsychotic neuroleptic. Goal d. The invention was to find a material and energy-saving process by an appropriate Reaktionsfuehrung and cleaning of the product. The process is characterized in that the reaction is carried out in a two-phase system consisting of dichloroethane and water at temperatures of +5 degrees C to the boiling point of the organic solvent with the addition of a base (eg NaHCO3 deep), all the drying of the organic phases Azeotoprektifikation be realized under vacuum with circling the water u. the cleansing. About the dichloroethane / gasoline crystallized hydrochloride erf.
priorityDate 1983-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454440542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159982625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162064837
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413336564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22598441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451435425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415735494
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID430084
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3908
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID430084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4678093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11

Total number of triples: 40.